The Clinical Investigator Collaborative (CIC) is unique globally in its ability to undertake early-stage clinical trials to evaluate the efficacy of new molecules that treat inflammation in the airways.
Read MoreCIC scientists, located at 6 sites across Canada, are opinion leaders renowned for their research accomplishments, their clinical expertise, and their ability to deliver high-quality results on time.
Read MoreCIC's track record conducting Phase Ib/IIa clinical trials of unsurpassed quality is attracting global investment and positioning Canada as a leader in airways disease research and drug development.
Read MoreBRONCHOPROVOCATION Inhaled allergen (PC20/PD20, early & late asthmatic responses) Methacholine airway hyperresponsiveness Inhaled mannitol (Aridol®) Exercise-induced bronchoconstriction Hypertonic […]
Across the Collaborative and within each study site, CIC employs the expertise of all the highly-trained research, technical […]
